Non-Hodgkin lymphoma.
Armitage JO, Gascoyne RD, Lunning MA, Cavalli F.
Lancet. 2017 Jul 15;390(10091):298-310. doi: 10.1016/S0140-6736(16)32407-2. Epub 2017 Jan 31.
Non-Hodgkin lymphoma.
Shankland KR, Armitage JO, Hancock BW.
Lancet. 2012 Sep 1;380(9844):848-57. doi: 10.1016/S0140-6736(12)60605-9. Epub 2012 Jul 25.
Intraspinal non-Hodgkin lymphoma with AIDS.
Guo S, Feng Z, Zhang Y, Bao C.
Asian J Surg. 2024 Feb;47(2):1256-1257. doi: 10.1016/j.asjsur.2023.11.056. Epub 2023 Nov 25.
Non-Hodgkin Lymphoma: Examining Mycosis Fungoides and Sezary Syndrome in the Context of Oncology Nursing.
Ow KV, Brant JM.
Clin J Oncol Nurs. 2021 Oct 1;25(5):555-562. doi: 10.1188/21.CJON.555-562.
[Non-Hodgkin lymphoma].
Bol P.
Ned Tijdschr Tandheelkd. 2002 Jul;109(7):267-8.
The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulation.
Fernandes M, Teixeira AL, Medeiros R.
Crit Rev Oncol Hematol. 2019 Dec;144:102825. doi: 10.1016/j.critrevonc.2019.102825. Epub 2019 Nov 2.
Paediatric non-Hodgkin lymphoma - perspectives in translational biology.
Shiramizu B, Mussolin L, Woessmann W, Klapper W.
Br J Haematol. 2016 May;173(4):617-24. doi: 10.1111/bjh.14009. Epub 2016 Mar 24.
The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma.
Dogan A.
Haematologica. 2023 May 1;108(5):1220-1221. doi: 10.3324/haematol.2022.281700.
CD83 in Hodgkin lymphoma.
Küppers R.
Haematologica. 2018 Apr;103(4):561-562. doi: 10.3324/haematol.2018.188870.
Targeting PI3K-Gamma in Non-Hodgkin Lymphoma.
Fruman DA.
J Clin Oncol. 2019 Apr 10;37(11):932-934. doi: 10.1200/JCO.19.00215. Epub 2019 Feb 27.
